+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Virus Filtration Market Size, Share & Trends Analysis Report By Product, By Technology (Filtration, Chromatography), By Application (Biologicals, Medical Devices), By End Use, And Segment Forecasts, 2019 - 2026

  • ID: 4396431
  • Report
  • 138 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Clean Cells Inc.
  • Danaher
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KGaA
  • Sartorius AG
  • MORE
The global virus filtration market size is expected to reach USD 7.0 billion by 2026, according to this report. It is anticipated to register a CAGR of 12.7% during the forecast period. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.

Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly made to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing R&D on biologics is expected to drive the product demand.

Further key findings from the report suggest:
  • Consumables was the largest revenue generating segment in 2018 owing to the increased usage of consumables including reagents, kits, and membranes in biologics downstream processing
  • Chromatography technology segment is projected to expand at the fastest CAGR during the forecast period, owing to advancements such as disposable or single-use membranes that eliminate the risk of a potential virus contaminant
  • Biologicals segment held the largest market share in 2018 and is projected to maintain its dominance during the forecast period due to rising prevalence of chronic diseases such as cancer, blood disorders, and diabetes
  • The biotechnology and biopharmaceutical companies segment is projected to expand at the fastest CAGR over the forecast period owing to increasing investment in R&D and production of biologics
  • North America led the virus filtration market in 2018 primarily due to the presence of several leading biotechnology companies and increased R&D activities
  • Asia Pacific is estimated to expand at the highest CAGR during the forecast period. Growing presence of CROs in countries including China and India due to the presence of a large genome pool, less stringent regulations, and availability of economical labor force is contributing to the regional growth
  • Some of the major players are Merck KGaA, Sartorius, Danaher, Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., GE Healthcare, Asahi Kasei Medical Co., Ltd., WuXi PharmaTech (Cayman) Inc., Lonza, and Clean Cells

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Clean Cells Inc.
  • Danaher
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KGaA
  • Sartorius AG
  • MORE
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market formulation & data visualization
1.6 Data Validation & Publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 Raw Material Trends
3.3.1.1 Major Raw Materials Market Analysis
3.3.1.2 Procurement Best Practices
3.3.2 Manufacturing Trends
3.3.2.1 Technology Trends
3.3.2.2 Outsourcing & Contract Manufacturing Trends
3.3.2.3 Cost Structure Analysis
3.3.3 User perspective analysis
3.3.3.1 Consumer Behavior Analysis
3.3.3.2 Market Influencer Analysis
3.3.4 Procedure cost analysis/breakdown
3.3.5 List of Key End-users, by region / by product / by country
3.4 Technology Overview
3.4.1 Technology Timeline
3.5 Regulatory Framework
3.5.1 Reimbursement framework
3.5.2 Standards & Compliances
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Rising demand for biologics
3.6.1.2 Increasing R&D investment
3.6.1.3 Compliance with regulatory framework
3.6.2 Market Restraint Analysis
3.6.2.1 Intense competition among vendors
3.6.3 Industry Opportunity
3.6.3.1 Growth in pharmaceutical outsourcing industry
3.6.3.2 Rising adoption of single-use technologies
3.6.4 Industry Challenges
3.6.4.1 Complexity of biologics
3.7 Virus Filtration Market Analysis Tools
3.7.1 Industry Analysis – Porter’s
3.7.1.1 Supplier Power
3.7.1.2 Buyer Power
3.7.1.3 Substitution Threat
3.7.1.4 Threat from new entrant
3.7.1.5 Competitive rivalry
3.7.2 PESTEL Analysis
3.7.2.1 Political Landscape
3.7.2.2 Environmental Landscape
3.7.2.3 Social Landscape
3.7.2.4 Technology Landscape
3.7.2.5 Legal Landscape
3.7.3 Major Deals & Strategic Alliances Analysis
3.7.4 Market Entry Strategies
3.7.5 Case Studies

Chapter 4 Virus Filtration Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key customers
4.2.3 Key company market share analysis, 2018
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Company market Share/Ranking, by region
4.3.3 Competitive dashboard analysis
4.3.3.1 Market differentiators
4.4 Private companies
4.4.1 List of key emerging companies’ /technology disruptors/innovators
4.4.2 Funding outlook
4.4.3 Regional network map
4.4.4 Company market position analysis
4.4.5 Supplier ranking

Chapter 5 Virus Filtration Market: Product Estimates and Trend Analysis
5.1 Definition and Scope
5.2 Product Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Virus Filtration Market, by Product, 2015 - 2026 (USD Million)
5.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Product
5.5.1 Consumables
5.5.1.1 Consumables market, 2015 - 2026 (USD Million)
5.5.1.2 Kits & reagents
5.5.1.2.1 Kits & reagents market, 2015 - 2026 (USD Million)
5.5.1.3 Others
5.5.1.3.1 Others market, 2015 - 2026 (USD Million)
5.5.2 Instruments
5.5.2.1 Instruments market, 2015 - 2026 (USD Million)
5.5.2.3 Filtration systems
5.5.2.3.1 Filtration systems market, 2015 - 2026 (USD Million)
5.5.2.4 Chromatography systems
5.5.2.4.1 Chromatography systems market, 2015 - 2026 (USD Million)
5.5.3 Services
5.5.3.1 Services market, 2015 - 2026 (USD Million)

Chapter 6 Virus Filtration Market: Technology Estimates and Trend Analysis
6.1 Definition and Scope
6.2 Technology Market Share Analysis, 2018 & 2026
6.3 Segment Dashboard
6.4 Global Virus Filtration Market, by Technology, 2015 - 2026 (USD Million)
6.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Technology
6.5.1 Filtration
6.5.1.1 Filtration market, 2015 - 2026 (USD Million)
6.5.1.2 Filtration market, by product, 2015 - 2026 (USD Million)
6.5.2 Chromatography
6.5.2.1 Chromatography market, 2015 - 2026 (USD Million)
6.5.2.2 Chromatography market, by product, 2015 - 2026 (USD Million)

Chapter 7 Virus Filtration Market: Application Estimates and Trend Analysis
7.1 Definition and Scope
7.2 Application Market Share Analysis, 2018 & 2026
7.3 Segment Dashboard
7.4 Global Virus Filtration Market, by Application, 2015 - 2026 (USD Million)
7.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Application
7.5.1 Biologicals
7.5.1.1 Biologicals market, 2015 - 2026 (USD Million)
7.5.1.2 Vaccines and therapeutics
7.5.1.2.1 Vaccines and therapeutics market, 2015 - 2026 (USD Million)
7.5.1.3 Blood and blood products
7.5.1.3.1 Blood and blood products market, 2015 - 2026 (USD Million)
7.5.1.4 Cellular and gene therapy products
7.5.1.4.1 Cellular and gene therapy products market, 2015 - 2026 (USD Million)
7.5.1.5 Tissue and tissue products
7.5.1.5.1 Tissue and tissue products market, 2015 - 2026 (USD Million)
7.5.1.6 Stem cell products
7.5.1.6.1 Stem cell products market, 2015 - 2026 (USD Million)
7.5.2 Medical Devices
7.5.2.1 Medical devices market, 2015 - 2026 (USD Million)
7.5.3 Water Purification
7.5.3.1 Water purification market, 2015 - 2026 (USD Million)
7.5.4 Air Purification
7.5.4.1 Air purification market, 2015 - 2026 (USD Million)

Chapter 8 Virus Filtration Market: End Use Estimates and Trend Analysis
8.1 Definition and Scope
8.2 End Use Market Share Analysis, 2018 & 2026
8.3 Segment Dashboard
8.4 Global Virus Filtration Market, by End Use, 2015 - 2026 (USD Million)
8.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by End Use
8.5.1 Biopharmaceutical & biotechnology companies
8.5.1.1 Biopharmaceutical & biotechnology companies market, 2015 - 2026 (USD Million)
8.5.2 CROs
8.5.2.1 CROs market, 2015 - 2026 (USD Million)
8.5.3 Medical devices companies
8.5.3.1 Medical devices companies market, 2015 - 2026 (USD Million)
8.5.4 Academic institutes & research laboratories
8.5.4.1 Academic institutes & research laboratories market, 2015 - 2026 (USD Million)

Chapter 9 Virus Filtration Market Regional Estimates & Trend Analysis, by Product, Technology, Application, End Use
9.1 Regional Market Snapshot
9.2 Regional Market Share and Leading Players, 2018
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa
9.3 Market Share Analysis by Country/ State
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Latin America
9.3.5 Middle East & Africa
9.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.4.1 North America
9.4.2 Europe
9.4.3 Asia Pacific
9.4.4 Latin America
9.4.5 Middle East & Africa
9.5 Market Size, & Forecasts and Trend Analysis, 2015 to 2026
9.6 North America
9.6.1 North America Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.6.2 U.S.
9.6.2.1 U.S. Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.6.3 Canada
9.6.3.1 Canada Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.7 Europe
9.7.1 Europe Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.7.2 Germany
9.7.2.1 Germany Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.7.3 U.K.
9.7.3.1 U.K. Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.7.4 France
9.7.4.1 France Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.7.5 Italy
9.7.5.1 Italy Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.7.6 Spain
9.7.6.1 Spain Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.7.7 Russia
9.7.7.1 Russia Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.8 Asia Pacific
9.8.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.8.2 Japan
9.8.2.1 Japan Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.8.3 China
9.8.3.1 China Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.8.4 India
9.8.4.1 India Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.8.5 South Korea
9.8.6.1 South Korea Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.8.7 Australia
9.8.7.1 Australia Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.8.8 Singapore
9.8.8.1 Singapore Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.9 Latin America
9.9.1 Latin America Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.9.2 Brazil
9.9.2.1 Brazil Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.9.3 Mexico
9.9.3.1 Mexico Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.9.4 Argentina
9.9.4.1 Argentina Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.10 Middle East and Africa
9.10.1 Middle East and Africa Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.10.2 South Africa
9.10.2.1 South Africa Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.10.3 Saudi Arabia
9.10.3.1 Saudi Arabia Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
9.10.4 UAE
9.10.4.1 UAE Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)

Chapter 10 COMPANY PROFILES
10.1 Merck KGaA
10.1.1 Company Overview
10.1.2 Financial performance
10.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
10.2 Danaher
10.2.1 Company Overview
10.2.2 Financial performance
10.2.3 Product Benchmarking
10.2.4 Strategic Initiatives
10.3 Sartorius AG
10.3.1 Company Overview
10.3.2 Financial performance
10.3.3 Product Benchmarking
10.3.4 Strategic Initiatives
10.4 Thermo Fisher Scientific Inc.
10.4.1 Company Overview
10.4.2 Financial performance
10.4.3 Product Benchmarking
10.4.4 Strategic Initiatives
10.5 GE Healthcare
10.5.1 Company Overview
10.5.2 Financial performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiatives
10.6 Charles River Laboratories International, Inc.
10.6.1 Company Overview
10.6.2 Financial performance
10.6.3 Product Benchmarking
10.6.4 Strategic Initiatives
10.7 Asahi Kasei Medical Co., Ltd.
10.7.1 Company Overview
10.7.2 Financial performance
10.7.3 Product Benchmarking
10.7.4 Strategic Initiatives
10.8 WuXi PharmaTech Inc.
10.8.1 Company Overview
10.8.2 Financial performance
10.8.3 Product Benchmarking
10.8.4 Strategic Initiatives
10.9 Lonza Group Ltd.
10.9.1 Company Overview
10.9.2 Financial performance
10.9.3 Product Benchmarking
10.9.4 Strategic Initiatives
10.10 Clean Cells Inc.
10.10.1 Company Overview
10.10.2 Financial performance
10.10.3 Product Benchmarking
10.10.4 Strategic Initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Merck KGaA
  • Danaher
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Charles River Laboratories International, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • WuXi PharmaTech Inc.
  • Lonza Group Ltd.
  • Clean Cells Inc.
Note: Product cover images may vary from those shown
Adroll
adroll